Be there in person to consolidate, catch up, and realize the potential of multi-specifics in multi-modal disease

Join 100+ key opinion leaders and decision-makers at the leading dedicated forum to bispecific and multi-specific antibody development

Engage in interactive discussions on integrating discovery chemistry and production scale-up, executing CMC strategies, and employing the latest manufacturing techniques, all of which are critical discussion points for drug developers trying to strengthen their pipelines

Make valuable industry connections to drive your clinical and antibody engineering strategies forward and deliver safe, efficacious therapies to the clinic to address the unmet clinical needs in oncology and autoimmune indications